CAI
Caris Life Sciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.15
+0.46 ▲ +2.60%
🌙 3월 13일 6:08 PM ET (한국 3/14 07:08)
$18.15
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.92 | Insider Own | 57.32% | Shs Outstand | 0.28B | Perf Week | -2.37% |
| Market Cap | 5.13B | Forward P/E | 43.09 | EPS next Y | 139.38% | Insider Trans | -0.04% | Shs Float | 0.12B | Perf Month | -15.58% |
| Enterprise Value | 4.76B | PEG | - | EPS next Q | -0.02 | Inst Own | 43.15% | Short Float | 5.4% | Perf Quarter | -33.03% |
| Income | -0.54B | P/S | 6.32 | EPS this Y | 143.21% | Inst Trans | 14.79% | Short Ratio | 2.78 | Perf Half Y | -46.95% |
| Sales | 0.81B | P/B | 8.88 | EPS next 5Y | - | ROA | -9.27% | Short Interest | 6.51M | Perf YTD | -32.73% |
| Book/sh | 2.04 | P/C | 6.41 | EPS past 3/5Y | -7.57% - | ROE | -45.37% | 52W High | -57.29% ($42.50) | Perf Year | - |
| Cash/sh | 2.83 | P/FCF | 86.65 | Sales past 3/5Y | 62.87% - | ROIC | -53.88% | 52W Low | 5.83% ($17.15) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 70.21 | EPS Y/Y TTM | -42.35% | Gross Margin | 66.4% | Volatility(W/M) | 5.05% 6.27% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5.86 | Sales Y/Y TTM | 96.97% | Oper. Margin | 5.56% | ATR (14) | 1.2 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.35 | EPS Q/Q | 231.62% | Profit Margin | -66.25% | RSI (14) | 37.14 | Recom | 1.27 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.85 | Sales Q/Q | 125.44% | SMA20 | -5.98% ($19.3) | Beta | - | Target Price | $33 |
| Payout | - | Debt/Eq | 0.74 | Earnings | 2000000 | SMA50 | -20.39% ($22.8) | Rel Volume | 0.72 | Prev Close | $17.69 |
| Employees | 1846 | LT Debt/Eq | 0.73 | EPS/Sales Surpr. | 477.32% 21.84% | SMA200 | -35.08% ($27.96) | Avg Volume(3M) | 2.34M | Price | $18.15 |
| IPO | 2025/6/18 | Option/Short | Yes/Yes | Trades | 16639 | Volume | 1,697,514 | Change | 2.6% |
뉴스 로딩 중...